Skip to main content
. 2019 Nov 13;18(1):9–13. doi: 10.1080/2090598X.2019.1690270

Table 1.

Initial presenting data of both groups.

Variable Group I (bilateral orchidectomy) Group II (degarelix) P
Number of patients 33 27  
Age, years, mean (SD) 67.73 (7.24) 67.80 (7.73) 0.973*
Gleason Groups, n (%)     0.027**
Group 1 6 (18.2) 2 (7.4)  
Group 2 3 (9.1) 2 (7.4)  
Group 3 6 (18.2) 15 (55.6)  
Group 4 10 (30.3) 2 (7.4)  
Group 5 8 (24.2) 6 (22.2)  
Serum PSA level (ng/mL), n (%)     0.912**
<20 4 (12.1) 4 (14.8)  
20–50 5 (15.2) 3 (11.1)  
>50 24 (72.7) 20 (74.1)  
Symptoms at presentation, n (%)      
LUTS 33 (100) 25 (92.5) 0.492***
Bone pain 21 (63.6) 15 (55.6) 0.791
Obstructive uropathy 6 (18.2) 0 0.024

*Chi-square test, **Monte Carlo correlation, ***Fisher’s exact correlation.